Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-007822

VP Clinical Reg Affairs bought 250 shares at $12.71 ($3,178)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Jaye VP Clinical Reg Affairs 2023-03-15 Purchase +250 $12.71 $3,178 257,745 D
Open-market purchases · 250 sh · avg $12.71 · $3,178
Loading xslF345X03/ownership.xml…